Endoplasmic reticulum stress induces hepatic plasminogen activator inhibitor 1 in murine nonalcoholic steatohepatitis

被引:3
|
作者
Olivares, Shantel [1 ,2 ]
Henkel, Anne S. [1 ,2 ]
机构
[1] Northwestern Univ, Dept Med, 320 E Super St,Tarry 15-705, Chicago, IL 60611 USA
[2] Jesse Brown VA Med Ctr, Chicago, IL USA
关键词
nonalcoholic fatty liver disease; unfolded protein response; X-box binding protein 1;
D O I
10.1096/fba.2020-00056
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasminogen activator inhibitor 1 (PAI-1) is a stress-responsive gene that is highly induced in nonalcoholic steatohepatitis (NASH). Endoplasmic reticulum (ER) stress is a salient feature of NASH, yet it is unknown whether ER stress contributes to hepatic PAI-1 induction in this disorder. Therefore, we aimed to (a) establish the role of ER stress in the regulation of hepatic Pai-1 expression, and (b) determine whether induction of Pai-1 in murine NASH is driven by ER stress. Hepatic Pai-1 expression was measured in C57BL/6 J mice and human HepG2 cells subjected to acute or prolonged pharmacologic ER stress. We found that hepatic Pai-1 expression was acutely suppressed in murine liver in response to severe ER stress followed by marked induction during the recovery phase of the ER stress response. Hepatic Pai-1 expression was induced in response to prolonged low-grade ER stress in mice. Induction of PAI-1 by ER stress in HepG2 cells was prevented by pharmacologic inhibition of MEK1/ERK signaling or by siRNA-mediated knockdown of XBP1, mediators of the recovery response to ER stress. Inhibiting ER stress with 4-phenylbutyric acid prevented hepatic Pai-1 induction in mice with diet-induced steatohepatitis. We conclude that hepatic Pai-1 is induced by ER stress via a pathway involving XBP1 and MEK1/ERK signaling, and induction of hepatic Pai-1 in murine NASH is mediated by ER stress. These data implicate ER stress as a novel mechanistic link between Pai-1 induction and NASH.
引用
收藏
页码:695 / 704
页数:10
相关论文
共 50 条
  • [41] Autophagy inhibitor chloroquine induces apoptosis of cholangiocarcinoma cells via endoplasmic reticulum stress
    Jia, Baoxing
    Xue, Yanan
    Yan, Xiaoyu
    Li, Jiuling
    Wu, Yao
    Guo, Rui
    Zhang, Juanjuan
    Zhang, Lichao
    Li, Yaping
    Liu, Yahui
    Sun, Liankun
    ONCOLOGY LETTERS, 2018, 16 (03) : 3509 - 3516
  • [42] High-mobility group box 1 induces endoplasmic reticulum stress and activates hepatic stellate cells
    He, Qin
    Fu, Yu
    Ding, Xiangming
    Li, Dongxiao
    Wang, Zi
    Tian, Dean
    Yan, Wei
    LABORATORY INVESTIGATION, 2018, 98 (09) : 1200 - 1210
  • [43] Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes
    Bator, JM
    Cohen, RL
    Chambers, DA
    EXPERIMENTAL CELL RESEARCH, 1998, 242 (01) : 110 - 119
  • [45] Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression
    Tsai, Shih-Jen
    ONCOTARGET, 2017, 8 (68) : 113258 - 113268
  • [46] Conservation of critical functional domains in murine plasminogen activator inhibitor-1
    Xu, Z
    Balsara, RD
    Gorlatova, NV
    Lawrence, DA
    Castellino, FJ
    Ploplis, VA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (17) : 17914 - 17920
  • [47] Protective function of plasminogen activator inhibitor type 1 in murine septic model
    Hou, BD
    Gleaves, L
    Walker, EB
    Dixon, JD
    Covington, JW
    Vaughan, DE
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (05) : A66 - A66
  • [48] Curcumin reduces the risk of chronic kidney damage in mice with nonalcoholic steatohepatitis by modulating endoplasmic reticulum stress and MAPK signaling
    Afrin, Rejina
    Arumugam, Somasundaram
    Rahman, Md. Azizur
    Karuppagounder, Vengadeshprabhu
    Harima, Meilei
    Suzuki, Hiroshi
    Miyashita, Shizuka
    Suzuki, Kenji
    Ueno, Kazuyuki
    Yoneyama, Hiroyuki
    Watanabe, Kenichi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 49 : 161 - 167
  • [49] Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke
    Johansson, L
    Jansson, JH
    Boman, K
    Nilsson, TK
    Stegmayr, B
    Hallmans, G
    STROKE, 2000, 31 (01) : 26 - 32
  • [50] Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis
    S. Yener
    M. Akarsu
    T. Demir
    B. Akinci
    O. Sagol
    F. Bayraktar
    M. A. Ozcan
    E. Tankurt
    S. Yesil
    Journal of Endocrinological Investigation, 2007, 30 : 810 - 819